Women's Health News

RSS

Stress-related psychiatric disorders more common among women: Study

There may be a biological reason why depression and other stress-related psychiatric disorders are more common among women compared to men. Studying stress signaling systems in animal brains, neuroscience researchers found that females are more sensitive to low levels of an important stress hormone and less able to adapt to high levels than males.

16 Jun 2010

Synthetic sutures less painful than natural "catgut" sutures after vaginal birth

Synthetic sutures appear to cause less pain than natural "catgut" sutures in women who receive stitches after a vaginal birth, according to a new review of studies.

16 Jun 2010

Exercise helps patients recover shoulder movement after breast cancer surgery

An active 72-year-old woman, Claire Mitchell had always enjoyed cooking. However, after breast cancer surgery she found that she had less freedom of movement and reaching jars on high shelves became quite painful. Her plight is common.

16 Jun 2010

Washington Post examines trial in Africa of long-acting vaginal ring for HIV prevention

"The first test of a long-acting vaginal ring loaded with an HIV-preventing drug has begun enrolling women in southern Africa," the Washington Post reports. The study, according to the newspaper, marks the 15th trial led by the nonprofit group, International Partnership for Microbicides, which "has helped lead the search for a discreet, woman-controlled means of protection" against the virus.

16 Jun 2010

Bayer sues Teva, Barr in connection with oral contraceptive Gianvi

Today, Bayer HealthCare Pharmaceuticals Inc. and Bayer Schering Pharma AG sued Teva Pharmaceuticals USA, Inc., Barr Pharmaceuticals LLC, and Barr Laboratories, Inc. in the Northern District of Illinois (Chicago) for false advertising and patent infringement in connection with Teva's generic oral contraceptive, Gianvi™. Teva's product is sold as a generic version of Bayer HealthCare's leading oral contraceptive YAZ®.

16 Jun 2010

Cytokine PharmaSciences completes misoprostol vaginal insert Phase II study

Cytokine PharmaSciences, Inc. today announced the completion of a Phase II study of the misoprostol vaginal insert (MVI), a proprietary, controlled-release and retrievable polymer chip containing prostaglandin E(1) (PGE1). Results of the dose-finding study in pregnant women at term gestation confirm the efficacy and safety of this investigational product and suggest that the MVI may reduce time to delivery after induction, support more natural labor, and reduce the rate of cesarean delivery.

16 Jun 2010

Expected 97% accuracy in ovarian cancer detection: Study underway

Now scientists in Melbourne have found a more effective test to detect ovarian cancer and hope to commence trials soon. This new test will check for two additional biomarkers that may indicate ovarian cancer in addition to conventional tests.

15 Jun 2010

Women who drink boiled coffee at lower risk of breast cancer

Women who drink Scandinavian boiled coffee, which chemically resembles of French press and Turkish/Greek coffee, more than four times a day run a lower risk of developing breast cancer than women who drink coffee less than once a day. This is shown by Lena Nilsson and her associates at Umeå University in an article in the journal Cancer Causes & Control.

15 Jun 2010

Female endurance sports athletes are at risk for serious health issues, say physicians

Female endurance sports athletes may be at risk for serious health issues, according to physicians at Loyola University Health System. Excessive exercise and inadequate nutrition can lead to problems such as low energy, menstrual irregularity, fertility issues, stress fractures and osteoporosis.

15 Jun 2010

Depression and other stress-related psychiatric disorders in women may have biological basis: Research

15 Jun 2010

Xoft reports clinical benefits of isotope-free electronic radiation therapy for treatment of cancer

The clinical benefits of isotope-free electronic radiation therapy delivered directly to cancer sites with minimal exposure to surrounding healthy tissue continues to be substantiated by multiple publications, according to Xoft, Inc., developer of the Axxent Electronic Brachytherapy, eBx System. The leading provider of FDA-cleared Electronic Brachytherapy Systems, Xoft provides systems for single-dose intraoperative radiation therapy and accelerated brachytherapy applications.

15 Jun 2010

Medicare coverage of unproven mammography screening device leads to surge in usage

In a study illustrating the potentially powerful influence of political pressure on medical practice, a UC Davis physician-researcher has found that use of a largely unproven mammography screening device has surged since Medicare began covering its cost.

15 Jun 2010

IRIN, IPS examine pending U.S. legislation to address global hunger, FGM

IRIN reports on the Global Food Security Act, a bill aimed at expanding the U.S. government's role in combatting hunger around the world. The legislation is co-sponsored by Sens. Richard Lugar (R-Ind.) and Bob Casey (D-Pa.).

15 Jun 2010

Media examine Women Deliver conference

As the conference closed, Women Deliver President Jill Sheffield said advocates would address the economic dimensions of maternal mortality, the BBC reports. "Finance ministers are on our list - and they're not going to stay safe," she said. "They don't always see this as a critical issue. Our economic arguments for investing in women's health are pretty dramatic."

15 Jun 2010

Texas prepares for health reform's changes despite opposition to new law; Other states brace for federal funding cuts

When Congress approved the sweeping federal health care overhaul in March, Texas Governor Rick Perry was one of the loudest critics. He blasted the initiative as unconstitutional, a government takeover of health care and an unfunded federal mandate on the states. … That sentiment remains widespread in Texas, which has joined with 20 other states in suing to block the law from taking effect.

15 Jun 2010

Agile Therapeutics completes $45 million Series B Preferred Stock financing round

Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.

14 Jun 2010

Abstract on Phase I/II DIGNITY trial of ThermoDox in RCW Breast Cancer accepted at ASTRO 2010

Celsion Corporation announced today that an abstract on the Phase I/II DIGNITY trial of ThermoDox in Recurrent Chest Wall Breast Cancer has been accepted for a poster session at the 52nd American Society for Radiation Oncology Annual Meeting. The abstract will provide updated clinical results, as well as the rationale and design of the DIGNITY study, which is evaluating ThermoDox in combination with microwave hyperthermia in women with RCW Breast Cancer.

14 Jun 2010

TF12 antibody targets EGP-1 expressed in epithelial cancer: Immunomedics

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that TF12, in combination with radiolabeled peptides, produced specific, fast, high-contrast imaging and pretargeted radioimmunotherapy of epithelial cancers that include cancers of the prostate and the ovary.

14 Jun 2010

Nurse with enhanced clinical skills detects same breast abnormalities as surgeon

UK researchers have developed an Initiative that could help hospitals prevent delays to the two-week cancer target, following the reduction in junior doctors' working hours due to the European Working Time Directive. A specially trained nurse practitioner and consultant breast surgeon who examined 126 women referred to a symptomatic breast disease clinic picked up the same breast abnormalities in 92% of cases.

14 Jun 2010

Children born after ART at increased risk of congenital malformation

Couples considering undergoing assisted reproductive technology (ART) treatment should be informed about the increased risk of congenital malformation posed by the use of ART, the annual conference of the European Society of Human Genetics will hear today (Monday). Dr. G-raldine Viot, a clinical geneticist at the Maternit- Port Royal hospital, Paris, France, will say that she believed that most doctors working in ART clinics in France only told couples about such risks if they were asked specific questions.

14 Jun 2010

Women's Health News

Stress-related psychiatric disorders more common among women: Study

Synthetic sutures less painful than natural "catgut" sutures after vaginal birth

Exercise helps patients recover shoulder movement after breast cancer surgery

Washington Post examines trial in Africa of long-acting vaginal ring for HIV prevention

Bayer sues Teva, Barr in connection with oral contraceptive Gianvi

Cytokine PharmaSciences completes misoprostol vaginal insert Phase II study

Expected 97% accuracy in ovarian cancer detection: Study underway

Women who drink boiled coffee at lower risk of breast cancer

Female endurance sports athletes are at risk for serious health issues, say physicians

Depression and other stress-related psychiatric disorders in women may have biological basis: Research

Xoft reports clinical benefits of isotope-free electronic radiation therapy for treatment of cancer

Medicare coverage of unproven mammography screening device leads to surge in usage

IRIN, IPS examine pending U.S. legislation to address global hunger, FGM

Media examine Women Deliver conference

Texas prepares for health reform's changes despite opposition to new law; Other states brace for federal funding cuts

Agile Therapeutics completes $45 million Series B Preferred Stock financing round

Abstract on Phase I/II DIGNITY trial of ThermoDox in RCW Breast Cancer accepted at ASTRO 2010

TF12 antibody targets EGP-1 expressed in epithelial cancer: Immunomedics

Nurse with enhanced clinical skills detects same breast abnormalities as surgeon

Children born after ART at increased risk of congenital malformation

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News